Skip to main content
. 2016 Jul 5;8(7):1361–1370. doi: 10.1080/19420862.2016.1204503

Figure 1.

Figure 1.

In vitro effect of anti-Her2 antibodies and F(ab’)2 on the proliferation of HER2+ tumors. Proliferation inhibition of the trastuzumab-sensitive BT-474 cell line (a,b) and the trastuzumab-resistant cell line JIMT-1 (c) was measured by an MTT-based colorimetric assay. All measured points are average ± SD of triplicates from ≥3 independent experiments normalized to untreated control. Half maximal effective inhibitory concentration (EC50) was calculated from the fitted dose-response curves.